Skip to main content

Table 4 Distribution of 145 pathogens in 138 laboratory-confirmed BSIs

From: Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland

Isolate

No of Isolates (n = 145)

CoNS (of these: methicillin-resistant)

50 (MRSE: 19)

Escherichia coli

22

α-hemolytic streptococci (Str. viridans)

21

Klebsiella pneumoniae

9

Pseudomonas aeruginosa

8

Staphylococcus aureus*

5

Enterobacter cloacae

4

Enterococcus spp.

3

Acinetobacter woffii

2

Bacillus spp.

2

Micrococcus spp.

2

Neisseria spp

2

Pantoea agglomerans

2

Vancomycin-resistant Enterococcus faecium (VRE)

2

Arthrobacter spp.

1

Burkholderia cepacia

1

Strep. Pneumoniae

1

Corynebacterium spp.

1

Kocuria kristinae

1

Leuconostoc spp.

1

MR-Klebsiella spp.

1

MR-Pseudomonas spp.

1

Proteus spp.

1

Ralstonia pickettii

1

Candida albicans

1

  1. BSI = bloodstream infection
  2. CoNS = coagulase-negative Staphylococci
  3. MRSE = methicillin-resistant coagulase-negative Staphylococci
  4. MR = multiresistant in vitro
  5. (here: to piperacillin, aminogylcosides and to 3rd generation cephalosporines)
  6. * No MRSA was detected.